142 (Bupropion Hydrochloride Extended-Release (XL) 300 mg)
Pill with imprint 142 is White, Elliptical / Oval and has been identified as Bupropion Hydrochloride Extended-Release (XL) 300 mg. It is supplied by Actavis.
Bupropion is used in the treatment of major depressive disorder; depression; smoking cessation; seasonal affective disorder and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 300 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for 142
Bupropion Hydrochloride Extended-Release (XL)
- Imprint
- 142
- Strength
- 300 mg
- Color
- White
- Size
- 17.00 mm
- Shape
- Elliptical / Oval
- Availability
- Prescription only
- Drug Class
- Miscellaneous antidepressants, Smoking cessation agents
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Actavis
- Inactive Ingredients
-
copovidone, hydroxypropyl cellulose (type h), silicon dioxide, magnesium stearate, polyvinyl alcohol, titanium dioxide, polyethylene glycol, magnesium silicate, methacrylic acid, triethyl citrate, sodium bicarbonate, sodium lauryl sulfate, povidone, water, hydrochloric acid
Note: Inactive ingredients may vary.
Labelers / Repackagers
| NDC Code | Labeler / Repackager |
|---|---|
| 67767-0142 | Actavis Pharma, Inc. |
| 45963-0142 | Actavis Pharma, Inc. |
Related Images for "142"
More about bupropion
- Side Effects
- During Pregnancy or Breastfeeding
- Dosage Information
- Patient Tips
- Drug Images
- Drug Interactions
- Compare Alternatives
- Support Group
- Pricing & Coupons
- En Español
- 2102 Reviews
- Drug class: miscellaneous antidepressants
- FDA Alerts (3)
Consumer resources
- Bupropion
- Bupropion Extended-Release Tablets
- Bupropion Sustained-Release Tablets (Smoking Deterrent)
- Bupropion Tablets and Sustained-Release Tablets
- Bupropion (Advanced Reading)
Other brands: Wellbutrin, Wellbutrin XL, Wellbutrin SR, Zyban, ... +5 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
